09:57 AM EST - Sernova Biotherapeutics : Announced the formation of its Clinical Advisory Board. The board will consist of five members and will be chaired by Dr. Robert Gabbay. This globally respected group of experts will provide critical guidance as the company advances clinical development of its Cell Pouch Bio-hybrid Organ with islet cells in patients with T1D. Sernova Biotherapeutics
shares T.SVA are trading down $0.01 at $0.22.
